Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
NF-κB in biology and targeted therapy: new insights and translational implications
Q Guo, Y **, X Chen, X Ye, X Shen, M Lin… - Signal transduction and …, 2024 - nature.com
NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was
identified as a pivotal pathway in mediating inflammatory responses. However, with …
identified as a pivotal pathway in mediating inflammatory responses. However, with …
[HTML][HTML] Polymer-and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives
H Han, S Li, M Xu, Y Zhong, W Fan, J Xu, T Zhou… - Advanced drug delivery …, 2023 - Elsevier
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
over 43 million blindness. However, efficient drug delivery to treat ocular diseases …
Poly(l‐Histidine)‐Mediated On‐Demand Therapeutic Delivery of Roughened Ceria Nanocages for Treatment of Chemical Eye Injury
Abstract Development of topical bioactive formulations capable of overcoming the low
bioavailability of conventional eye drops is critically important for efficient management of …
bioavailability of conventional eye drops is critically important for efficient management of …
[HTML][HTML] Role and mechanisms of the NF-ĸB signaling pathway in various developmental processes
P Liu, Y Li, W Wang, Y Bai, H Jia, Z Yuan… - Biomedicine & …, 2022 - Elsevier
Since the discovery of the nuclear factor kappa B (NF-ĸB) transcription factor 36 years ago,
many studies have linked the NF-ĸB signaling pathway to pathological and physiological …
many studies have linked the NF-ĸB signaling pathway to pathological and physiological …
Current and emerging therapies for corneal neovascularization
The cornea is unique because of its complete avascularity. Corneal neovascularization
(CNV) can result from a variety of etiologies including contact lens wear; corneal infections; …
(CNV) can result from a variety of etiologies including contact lens wear; corneal infections; …
[HTML][HTML] Up-to-date molecular medicine strategies for management of ocular surface neovascularization
Ocular surface neovascularization and its resulting pathological changes significantly alter
corneal refraction and obstruct the light path to the retina, and hence is a major cause of …
corneal refraction and obstruct the light path to the retina, and hence is a major cause of …
Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics
Ocular delivery is the most challenging aspect in the field of pharmaceutical research. The
major hurdle for the controlled delivery of drugs to the eye includes the physiological static …
major hurdle for the controlled delivery of drugs to the eye includes the physiological static …
Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB
Z Huang, T Mou, Y Luo, X Pu, J Pu, L Wan… - Cell Death & …, 2020 - nature.com
Hepatic ischemia/reperfusion injury (IRI) is an unavoidable course in liver transplantation,
during which the immune response of inflammation plays a leading part. MicroRNA-450b-5p …
during which the immune response of inflammation plays a leading part. MicroRNA-450b-5p …
Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathway
Abstract Development of chemoresistance in breast cancer patients greatly increases
mortality. Thus, understanding mechanisms underlying breast cancer resistance to …
mortality. Thus, understanding mechanisms underlying breast cancer resistance to …
Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core–shell nanoparticles for enhanced tumor-localized …
T Wang, J Zhang, T Hou, X Yin, N Zhang - Nanoscale, 2019 - pubs.rsc.org
Tumor associated macrophage (TAM)-based immunotherapy has been presented as a
promising strategy in cancer therapy. The combination of TAM-based immunotherapy with …
promising strategy in cancer therapy. The combination of TAM-based immunotherapy with …